Related Experiment Video

Updated: May 12, 2026

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry
10:54

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry

Published on: November 21, 2025

MacroH2A--an epigenetic regulator of cancer

Neus Cantariño1, Julien Douet, Marcus Buschbeck

  • 1Institute for Predictive and Personalized Medicine of Cancer (IMPPC), Crta. Can Ruti, Cami de les Escoles, 08916 Badalona, Barcelona, Spain.

Cancer Letters
|March 28, 2013
PubMed

Insights

MacroH2A histone variants, key in epigenetics, show tumor-suppressive functions in cancer research. Understanding their specific roles offers potential for new cancer biomarkers and therapies.

Area of Science:

  • Epigenetics and Cancer Research
  • Chromatin Biology
  • Molecular Oncology

Background:

  • Epigenetic regulation is crucial in cancer research.
  • Histone variants, like macroH2A, play underappreciated roles in chromatin and gene regulation.
  • Loss-of-function studies highlight macroH2A's significance in cellular processes.

Purpose of the Study:

  • To review molecular mechanisms underlying the tumor-suppressive functions of macroH2A.
  • To explore context-dependent and isoform-specific roles of macroH2A.
  • To guide research on macroH2A as a potential cancer biomarker and therapeutic target.

Main Methods:

  • Literature review of existing studies on macroH2A.
  • Analysis of molecular mechanisms of histone variant function.
  • Synthesis of data on macroH2A's role in cancer.

Main Results:

  • MacroH2A variants exhibit primarily tumor-suppressive functions.
  • Specific molecular mechanisms mediate macroH2A's epigenetic roles.
  • Functions are context-dependent and vary between macroH2A isoforms.

Conclusions:

  • MacroH2A variants are critical epigenetic regulators with significant tumor-suppressive potential.
  • Further research into macroH2A's specific functions is warranted.
  • MacroH2A represents a promising avenue for cancer biomarker development and therapeutic strategies.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...